Table IV.

Univariable Logistic Regression Models for Black Participants in SARP (n=267)

Variable	Coeff	SE	OR	95% CI	G	p
Age Onset	0.006	0.0090	1.01	0.99–1.02	0.45	0.503
Age	0.057	0.0119	1.06	1.03–1.08	22.63	<.0001
Female	0.176	0.2745	1.19	0.70–2.04	0.41	0.521
Center	−0.112	0.0462	0.89	0.82–0.98	5.83	0.016
BMI	0.033	0.0142	1.03	1.01–1.06	5.36	0.021
Employed	−0.376	0.2559	0.69	0.42–1.13	2.16	0.141
2nd Smoke	−0.205	0.2660	0.82	0.48–1.37	0.59	0.442
Pets	0.042	0.3008	1.04	0.58–1.88	0.02	0.889
GERD	0.977	0.2865	2.66	1.52–4.66	11.63	0.001
Diabetes	0.647	0.4681	1.91	0.76–4.78	1.91	0.167
HTN	0.409	0.2988	1.51	0.84–2.70	1.87	0.171
FEV1% pred	−0.031	0.0066	0.97	0.96–0.98	22.07	<.0001
FEV1 liters	−1.397	0.2312	0.25	0.16–0.39	36.54	<.0001
% Eosinophil	0.007	0.0351	1.01	0.94–1.08	0.04	0.849
Reversal	0.0067	0.0061	1.01	0.995–1.02	1.18	0.277
IgE	0.075	0.2077	1.08	0.72–1.62	0.13	0.717
≥5 skin tests	−0.486	0.2843	0.62	0.35–1.07	2.92	0.088
Atopy	−1.009	0.2855	0.37	0.21–0.64	12.50	0.0004
1 Fam Hx	−0.065	0.3090	0.94	0.51–1.72	0.04	0.834
2+ Fam Hx	0.511	0.3166	1.67	0.90–3.10	2.61	0.106

^*Age Onset=Age when first diagnosed with asthma, Age=Age when enrolled into SARP, Center= clinical center site, 2^ndhand smoke=exposure to secondhand smoke during day, Pets=own any pets, GERD=gastroesophogeal reflux disease, HTN=hypertension diagnosis, FEV1=forced expiratory volume in one second, % Eosinophil=% of eosinophils in the blood, Reversal=Max FEV1 reversal, IgE=Immunoglobulin E, ≥5 skin tests= 5 or more positive skin tests, 1 Family Hx= Have 1 family member with asthma, 2+ Family Hx= Have 2 or more family members with asthma

^*IgE entered as continuous log-transformed variables in the model